<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is evidence indicating that <z:chebi fb="0" ids="3098">bile acid</z:chebi> is a promoter of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="28834">Deoxycholic acid</z:chebi> modifies <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation by affecting intracellular signaling and gene expression </plain></SENT>
<SENT sid="2" pm="."><plain>We are interested in revealing the relationship between deregulated miRNAs and <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development </plain></SENT>
<SENT sid="3" pm="."><plain>We found that miR-199a-5p was expressed at a low level in human primary colonic epithelial cells treated with <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> compared with control, and miR-199a-5p was significantly down-regulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="4" pm="."><plain>The miR-199a-5p expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells led to the suppression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell growth, migration and invasion </plain></SENT>
<SENT sid="5" pm="."><plain>We further identified CAC1, a cell cycle-related protein expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, as a miR-199a-5p target </plain></SENT>
<SENT sid="6" pm="."><plain>We demonstrated that CAC1 is over-expressed in <z:mp ids='MP_0002018'>malignant tumors</z:mp>, and cellular CAC1 <z:mpath ids='MPATH_63'>depletion</z:mpath> resulted in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> growth suppression </plain></SENT>
<SENT sid="7" pm="."><plain>HCT-8 cells transfected with a miR-199a-5p mimic or inhibitor had a decrease or increase in CAC1 protein levels, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The results of the luciferase reporter gene analysis demonstrated that CAC1 was a direct miR-199a-5p target </plain></SENT>
<SENT sid="9" pm="."><plain>The high miR-199a-5p expression and low CAC1 protein expression reverse the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell drug resistance </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that miR-199a-5p can regulate CAC1 and function as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, the potential roles of <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> are to decrease miR-199a-5p expression and/or increase the expression of CAC1, which contributes to <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>These findings suggest that miR-199a-5p is a useful therapeutic target for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>